Preprint Article Version 1 This version is not peer-reviewed

Nanoparticles as Potential Delivery System of Phenothiazine Derivatives for Anticancer Application

Version 1 : Received: 7 October 2024 / Approved: 7 October 2024 / Online: 8 October 2024 (08:56:24 CEST)

How to cite: Jelonek, K.; Musiał-Kulik, M.; Pastusiak, M.; Foryś, A.; Zięba, A.; Kasperczyk, J. Nanoparticles as Potential Delivery System of Phenothiazine Derivatives for Anticancer Application. Preprints 2024, 2024100517. https://doi.org/10.20944/preprints202410.0517.v1 Jelonek, K.; Musiał-Kulik, M.; Pastusiak, M.; Foryś, A.; Zięba, A.; Kasperczyk, J. Nanoparticles as Potential Delivery System of Phenothiazine Derivatives for Anticancer Application. Preprints 2024, 2024100517. https://doi.org/10.20944/preprints202410.0517.v1

Abstract

Cancer remains a one of a leading cause of death worldwide, and thus there is a need for the de-velopment of innovative and more effective treatment strategies. The aim of the study was to evaluate two types of nanoparticles – nanospheres and micelles obtained from PLA-based pol-ymers for discovering their potential for delivery of four types of phenothiazine derivatives. The morphology, drug loading properties, cytocompatibility, hemolytic properties and anti-cancer activity has been analyzed. The micelles exhibited significantly higher drug loading properties, release process and cytotoxic activity against cancer cells compared to the nano-spheres. The micelles containing 5-methyl-12H-quino[3,4-b][1,4]benzothiazinium chloride with OH group as substituent in 10-position of the quinobenzothiazine ring showed the highest drug loading content, the most efficient drug release, the lowest hemolytic activity and the most sig-nificant cytotoxic effect against HeLa cells. The conducted study enabled to develop delivery system for the new anticancer compound and showed that the choice of drug carrier has a crucial effect on its cytotoxic potential against cancer cells.

Keywords

phenothiazine; phenothiazine derivatives; drug delivery system; nanoparticles; nanocarriers; anticancer drugs

Subject

Medicine and Pharmacology, Pharmacy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.